COST-EFFECTIVENESS AND PUBLIC HEALTH IMPACT OF A NINE-VALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN UKRAINE

被引：0
|
作者：
Ugrekhelidze, D. [1 ]
Pavelyev, A. [2 ]
Daniels, V [3 ]
Grubaia, A. [4 ]
Fedotova, K. [4 ]
机构：
[1] MSD, Zurich, Switzerland
[2] Merck & Co Inc, Rahway, NJ USA
[3] Merck & Co Inc, Rahway, NJ USA
[4] MSD, Kiev, Ukraine
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE596
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    Habbema, J. Dik F.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (15) : 1083 - 1092
  • [32] Cost-effectiveness of human papillomavirus vaccination in the United States
    Chesson, Harrell W.
    Ekwueme, Donatus U.
    Saraiya, Mona
    Markowitz, Lauri E.
    [J]. EMERGING INFECTIOUS DISEASES, 2008, 14 (02) : 244 - 251
  • [33] Cost-effectiveness of human papillomavirus vaccination and screening in Spain
    Diaz, Mireia
    de Sanjose, Silvia
    Ortendahl, Jesse
    O'Shea, Meredith
    Goldie, Sue J.
    Bosch, F. Xavier
    Kim, Jane J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2973 - 2985
  • [34] RETRACTED: Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns (Retracted Article)
    Portnoy, Allison
    Campos, Nicole G.
    Sy, Stephen
    Burger, Emily A.
    Cohen, Jamie
    Regan, Catherine
    Kim, Jane J.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (01) : 22 - 30
  • [35] THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION IN ESTONIA
    Posiuniene, I
    Saar, I
    Van de Velde, N.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A583 - A583
  • [36] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF MALARIA ROUTINE VACCINATION IN INFANTS
    Sauboin, C.
    Sicuri, E.
    Van Bellinghen, L.
    Van de Velde, N.
    Van Vlaenderen, I
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A338 - A339
  • [37] Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands
    Simons, Joost J. M.
    Vida, Nora
    Westra, Tjalke A.
    Postma, Maarten J.
    [J]. VACCINE, 2020, 38 (30) : 4687 - 4694
  • [38] Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
    Simons, Joost J. M.
    Westra, Tjalke A.
    Postma, Maarten J.
    [J]. PREVENTIVE MEDICINE REPORTS, 2022, 28
  • [39] COST-EFFECTIVENESS OF ADDITIONAL HUMAN PAPILLOMAVIRUS VACCINATION PROGRAMMES, IN THE NETHERLANDS
    Setiawan, D.
    Westra, T. A.
    Daemen, T.
    Nijman, H. W.
    Wilschut, J. C.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A443 - A443
  • [40] Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    Coupe, Veerle M. H.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (05)
12345